BridgeBio Pharma BBIO
NASDAQ BBIO
$67.57 +0.02 (+0.03%)
As of: Oct 21, 2026 · 10:04 AM EDT

BridgeBio Pharma (BBIO) Current Taxes (2024 - 2025)

Updated

BridgeBio Pharma's Current Taxes was $2.1 million in Q2 2025.

Analysis

BridgeBio Pharma (BBIO) Current Taxes (2024 - 2025) Analysis & Trends

At the end of FY2024, Current Taxes at BridgeBio Pharma came in at $1.15 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,133.43 Bn 1,102.02 Bn 19.71 Bn -
2 Johnson & Johnson 615.31 Bn 533.83 Bn 17.26 Bn 1.05 Bn
3 AbbVie 505.93 Bn 479.05 Bn 12.70 Bn -
4 Merck 367.07 Bn 321.44 Bn 12.21 Bn 4.22 Bn
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn 2.31 Bn
6 Astrazeneca 261.59 Bn 235.28 Bn 12.86 Bn 1.47 Bn
7 Amgen 236.28 Bn 191.68 Bn 7.24 Bn -
8 Gilead Sciences 190.31 Bn 164.51 Bn 6.22 Bn -
9 Pfizer 170.69 Bn 117.33 Bn 10.94 Bn 653.00 Mn
10 BridgeBio Pharma 13.28 Bn 10.38 Bn 228.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 2.10 Mn
Dec 31, 2024 1.15 Mn
API Access

BridgeBio Pharma Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=BBIO&period=max&api_key=YOUR_API_KEY